AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34772433 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity Mediterranean diet intervention
Number of subjects: 100
Study 34772433 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care arm
Number of subjects: 100
Study 34772439 — intervention group
Group type: EXPERIMENTAL
Intervention: GD2.CAR T-cells
Number of subjects: 0
Study 34772439 — intervention group
Group type: EXPERIMENTAL
Intervention: PMN-MDSC
Number of subjects: 0
Study 34772665 — intervention group
Group type: EXPERIMENTAL
Intervention: EYEMATE-SC sensor implantation
Number of subjects: 24
Study 34772665 — intervention group
Group type: EXPERIMENTAL
Intervention: EYEMATE-SC sensor measurements
Number of subjects: 24
Study 34772665 — intervention group
Group type: EXPERIMENTAL
Intervention: EYEMATE-SC sensor
Number of subjects: 24
Study 34772746 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation programme (12 weekly sessions of 1.5 hours each)
Number of subjects: 30
Study 34772746 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation programme
Number of subjects: 30
Study 34772747 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilient Caregivers intervention (seven manualised group sessions, 2.5 hours each)
Number of subjects: 80
Study 34772747 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 80
Study 34772758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremelimumab (10 mg/kg) + MEDI3617 (200 mg)
Number of subjects: 15
Study 34772758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremelimumab (10 mg/kg) + MEDI3617 (600 mg)
Number of subjects: 15
Study 34772758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremelimumab + MEDI3617
Number of subjects: 15
Study 34772767 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients dissatisfied with care (scored 0 to 5 on a 0 to 10 scale)
Number of subjects: 1697
Study 34772767 — intervention group
Group type: COMPARATOR
Intervention: Patients satisfied with care (scored 9 to 10 on a 0 to 10 scale)
Number of subjects: 1697
Study 34773516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary resuscitation (CPR) attempt
Number of subjects: 186
Study 34773516 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis-related organ failure assessment score > 9 before CA occurrence
Number of subjects: 186
Study 34773596 — intervention group
Group type: EXPERIMENTAL
Intervention: fNIRS-guided rTMS treatment (n=20)
Number of subjects: 51
Study 34773596 — intervention group
Group type: EXPERIMENTAL
Intervention: MEP-guided rTMS treatment (n=16)
Number of subjects: 51
Study 34773596 — intervention group
Group type: COMPARATOR
Intervention: Sham group (n=15)
Number of subjects: 51
Study 34774057 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management and Resiliency Training Program for Residents (SMART-R)
Number of subjects: 0
Study 34774057 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART-R
Number of subjects: 0
Study 34774099 — intervention group
Group type: EXPERIMENTAL
Intervention: Wen Xin granular
Number of subjects: 502
Study 34774099 — intervention group
Group type: COMPARATOR
Intervention: Wen Xin granular placebo
Number of subjects: 502
Study 34774107 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSCs
Number of subjects: 15
Study 34774107 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSCs with IFNγ or IFNγ + TNFα
Number of subjects: 15
Study 34774107 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSCs with IFNγ
Number of subjects: 15
Study 34774105 — intervention group
Group type: COMPARATOR
Intervention: Oculomotor tasks (Gap, Step, Overlap, Antisaccade)
Number of subjects: 82
Study 34774105 — intervention group
Group type: COMPARATOR
Intervention: Antisaccade task
Number of subjects: 82
Study 34774105 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis with ADHD comorbidity index and executive functioning scales
Number of subjects: 82
Study 34774184 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34774363 — intervention group
Group type: EXPERIMENTAL
Intervention: Persuasive messaging that invokes prosocial vaccination and social image concerns
Number of subjects: 0
Study 34774363 — intervention group
Group type: EXPERIMENTAL
Intervention: Persuasive messaging based on contemporary concerns (restricting personal freedom, economic security)
Number of subjects: 0
Study 34774363 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial messaging
Number of subjects: 0
Study 34774528 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty
Number of subjects: 284
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to BP measurement guidelines
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling on weight, nutrition, and lifestyle
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up recommendations for high BP
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled follow-up at appropriate intervals
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation of appropriate diagnosis for third high BP measurement
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Conducting appropriate screening laboratory tests
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal ultrasound performance
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling odds related to BMI
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling odds related to BP
Number of subjects: 2677
Study 34774574 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation of hypertension
Number of subjects: 2677
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: ERA-2 (after August 2014)
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume centers
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: No competition centers
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: Male recipients
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatocellular carcinoma
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume center
Number of subjects: 4238
Study 34774638 — intervention group
Group type: EXPERIMENTAL
Intervention: MELD ≥30
Number of subjects: 4238
Study 34774736 — intervention group
Group type: EXPERIMENTAL
Intervention: Family asthma management system scale (FAMSS)
Number of subjects: 388
Study 34774736 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMSS integration subscale
Number of subjects: 388
Study 34774736 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMSS family response scores
Number of subjects: 388
Study 34774736 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMSS collaboration scores
Number of subjects: 388
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Atrial Stiffness Index (LA stiffness index)
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Atrial Reservoir Strain
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Atrial Conduit Strain
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak Oxygen Uptake (peak VO2)
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: LA dysfunction
Number of subjects: 75
Study 34774747 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic target
Number of subjects: 75
Study 34775134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colistin methanesulfonate (CMS) at 2.5-5.0 mg/kg/day
Number of subjects: 25
Study 34775220 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (neutralizing monoclonal antibody)
Number of subjects: 70
Study 34775220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 34775220 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-1654 (≥ 75 mg)
Number of subjects: 70
Study 34775477 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 1179
Study 34775477 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1179
Study 34775592 — intervention group
Group type: EXPERIMENTAL
Intervention: CD57+ NKG2C+ phenotype in SARS-CoV-2 convalescent donors
Number of subjects: 0
Study 34775804 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab after radiotherapy
Number of subjects: 0
Study 34775804 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 0
Study 34775952 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-based assessment of physical activity (PA)
Number of subjects: 355
Study 34776249 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HADS) during lockdown
Number of subjects: 134
Study 34776249 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Anxiety and Depression Scale (HADS)
Number of subjects: 134
Study 34776249 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived knowledge about COVID-19
Number of subjects: 134
Study 34776384 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment with management (GAM) intervention
Number of subjects: 0
Study 34776384 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 0
Study 34776902 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI intervention
Number of subjects: 16
Study 34777207 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy
Number of subjects: 0
Study 34777207 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34777240 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of predicted lean body mass index (LBMI) among men
Number of subjects: 9022
Study 34777240 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of predicted fat mass index (FMI) among men
Number of subjects: 9022
Study 34777240 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of predicted lean body mass index (LBMI) among women
Number of subjects: 9022
Study 34777240 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of predicted fat mass index (FMI) among women
Number of subjects: 9022
Study 34777337 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 0
Study 34777341 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PIV group (PIV < median)
Number of subjects: 53
Study 34777341 — intervention group
Group type: EXPERIMENTAL
Intervention: High PILE score
Number of subjects: 53
Study 34777343 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 weeks of community-based exercise training (3 x 40 - 60 minute mixed mode aerobic exercises, comprising 10 - 30 minutes aerobic and 30 minutes resistance training)
Number of subjects: 16
Study 34777343 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 weeks of community-based exercise training
Number of subjects: 16
Study 34777343 — intervention group
Group type: COMPARATOR
Intervention: Acute bout of cycling (45 minutes)
Number of subjects: 16
Study 34777367 — intervention group
Group type: EXPERIMENTAL
Intervention: hCART19s + Allogeneic Hematopoietic Stem Cell Transplantation (CART+HSCT group)
Number of subjects: 28
Study 34777367 — intervention group
Group type: COMPARATOR
Intervention: hCART19s (CART2 group)
Number of subjects: 28
Study 34777367 — intervention group
Group type: COMPARATOR
Intervention: hCART19s (CART1 group)
Number of subjects: 28
Study 34777367 — intervention group
Group type: EXPERIMENTAL
Intervention: hCART19s
Number of subjects: 28
Study 34778037 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO (15,000 U, q.d. for 7 days/month for at least 3 months)
Number of subjects: 35
Study 34778037 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone (non-rhTPO)
Number of subjects: 35
Study 34778141 — intervention group
Group type: EXPERIMENTAL
Intervention: Body composition and physical fitness interventions, specific details not available
Number of subjects: 0
Study 34778483 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge-enhanced anterior cruciate ligament repair (BEAR)
Number of subjects: 100
Study 34778483 — intervention group
Group type: COMPARATOR
Intervention: Autograft anterior cruciate ligament reconstruction (ACLR)
Number of subjects: 100
Study 34778571 — intervention group
Group type: EXPERIMENTAL
Intervention: adjunctive dexamethasone
Number of subjects: 0
Study 34778571 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 34778688 — intervention group
Group type: EXPERIMENTAL
Intervention: App-delivered mindfulness meditation for 6 weeks
Number of subjects: 0
Study 34778688 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 34778701 — intervention group
Group type: EXPERIMENTAL
Intervention: New medical therapy
Number of subjects: 108
Study 34778952 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive treatment
Number of subjects: 3807
Study 34778952 — intervention group
Group type: COMPARATOR
Intervention: Oral alkylating agents with or without steroids
Number of subjects: 3807
Study 34778952 — intervention group
Group type: COMPARATOR
Intervention: Calcineurin inhibitors (CNI) with or without steroids
Number of subjects: 3807
Study 34778952 — intervention group
Group type: COMPARATOR
Intervention: CNI with or without steroids
Number of subjects: 3807
Study 34778998 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutimlimab, an investigational C1s inhibitor
Number of subjects: 0
Study 34779146 — intervention group
Group type: EXPERIMENTAL
Intervention: short-term preoperative endocrine therapy (pET) with tamoxifen or aromatase inhibitors
Number of subjects: 622
Study 34779146 — intervention group
Group type: EXPERIMENTAL
Intervention: tamoxifen-based pET
Number of subjects: 622
Study 34779146 — intervention group
Group type: EXPERIMENTAL
Intervention: aromatase inhibitor-based pET
Number of subjects: 622
Study 34779236 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34779245 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean pulse pressure quartiles (<47, 48-53, 54-59, ≥60 mm Hg)
Number of subjects: 1454
Study 34779245 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean pulse pressure as a continuous variable
Number of subjects: 1454
Study 34779245 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial pressure in the highest quartile
Number of subjects: 1454
Study 34779245 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-dependent area under the receiver operating characteristic curve for hemorrhagic stroke
Number of subjects: 1454
Study 34779776 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraprocessed foods (UPFs) consumption
Number of subjects: 24
Study 34779776 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental food educational style (restrictive)
Number of subjects: 24
Study 34779776 — intervention group
Group type: COMPARATOR
Intervention: Parental restriction score
Number of subjects: 24
Study 34779779 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Text Messaging System (aTS)
Number of subjects: 71
Study 34779785 — intervention group
Group type: EXPERIMENTAL
Intervention: MyBack website
Number of subjects: 150
Study 34779785 — intervention group
Group type: COMPARATOR
Intervention: Wikipedia
Number of subjects: 150
Study 34779785 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability test
Number of subjects: 150
Study 34779785 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficient
Number of subjects: 150
Study 34779785 — intervention group
Group type: EXPERIMENTAL
Intervention: Construct validity
Number of subjects: 150
Study 34779843 — intervention group
Group type: EXPERIMENTAL
Intervention: EyeArt Automated DR Detection System, version 2.1.0
Number of subjects: 893
Study 34779920 — intervention group
Group type: EXPERIMENTAL
Intervention: Established pelvic LRTIs
Number of subjects: 107
Study 34779920 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher symptom burden and psychological distress
Number of subjects: 107
Study 34780067 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 13029
Study 34780067 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 13029
Study 34780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression analysis for parenchymal injury
Number of subjects: 337
Study 34780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression analysis for late fibrosis
Number of subjects: 337
Study 34780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic steatohepatitis classifier
Number of subjects: 337
Study 34780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrosis prediction using PC2
Number of subjects: 337
Study 34780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular fibrosis classifier
Number of subjects: 337
Study 34780125 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) sampling during immunotherapy trials
Number of subjects: 44
Study 34780125 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) sampling
Number of subjects: 44
Study 34780283 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop Insulin Dosing System
Number of subjects: 0
Study 34780283 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 34780623 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (1.2 mg/kg every 21 days) and Lenalidomide (20 mg/d for a maximum of 16 cycles)
Number of subjects: 37
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 25 mg twice daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 50 mg twice daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 100 mg twice daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 200 mg twice daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 25 mg once daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 50 mg once daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian 200 mg once daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 40 mg once daily
Number of subjects: 1242
Study 34780683 — intervention group
Group type: EXPERIMENTAL
Intervention: Milvexian (all doses)
Number of subjects: 1242
Study 34780683 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 1242
Study 34780709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceritinib 510 mg/m²
Number of subjects: 83
Study 34780709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceritinib 500 mg/m²
Number of subjects: 83
Study 34780712 — intervention group
Group type: EXPERIMENTAL
Intervention: Li-Fraumeni syndrome
Number of subjects: 480
Study 34781168 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 500 mg QD + paclitaxel 80 mg/m²
Number of subjects: 51
Study 34781168 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2780301 + weekly paclitaxel
Number of subjects: 51
Study 34781256 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine plus amodiaquine (5 monthly rounds)
Number of subjects: 350
Study 34781256 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated children)
Number of subjects: 350
Study 34781256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Sulfadoxine-pyrimethamine plus amodiaquine)
Number of subjects: 350
Study 34781256 — intervention group
Group type: EXPERIMENTAL
Intervention: Community acceptance of SMC
Number of subjects: 350
Study 34781313 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of sensor technology in disposable body-worn incontinence materials
Number of subjects: 0
Study 34781360 — intervention group
Group type: EXPERIMENTAL
Intervention: Early disease (ED) cohort (n = 37)
Number of subjects: 59
Study 34781360 — intervention group
Group type: COMPARATOR
Intervention: Advanced disease (AD) cohort (n = 16)
Number of subjects: 59
Study 34781360 — intervention group
Group type: EXPERIMENTAL
Intervention: ED1 cohort (n = 24)
Number of subjects: 59
Study 34781360 — intervention group
Group type: EXPERIMENTAL
Intervention: ED2 cohort (n = 13)
Number of subjects: 59
Study 34781360 — intervention group
Group type: COMPARATOR
Intervention: AD cohort (n = 16)
Number of subjects: 59
Study 34781360 — intervention group
Group type: EXPERIMENTAL
Intervention: ED cohort (n = 37)
Number of subjects: 59
Study 34781360 — intervention group
Group type: COMPARATOR
Intervention: Unrelated umbilical cord grafts
Number of subjects: 59
Study 34781890 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical measured ultrafiltration
Number of subjects: 261
Study 34781890 — intervention group
Group type: EXPERIMENTAL
Intervention: Real ultrafiltration
Number of subjects: 261
Study 34781890 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage conditions and type of dialysate package
Number of subjects: 261
Study 34781890 — intervention group
Group type: COMPARATOR
Intervention: Non-PVC package
Number of subjects: 261
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: RVO affected eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: RVO contralateral eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: COMPARATOR
Intervention: Healthy control eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: PDR eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: NPDR eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: COMPARATOR
Intervention: NDR eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal blood flow in RVO eyes
Number of subjects: 79
Study 34781913 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal blood flow in contralateral eyes
Number of subjects: 79